Catalyst Pharmaceuticals (CPRX) Free Cash Flow (QoQ) (2010 - 2026)
Catalyst Pharmaceuticals (CPRX) Free Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - |
| 3 | Akari Therapeutics | 1,021.31 Bn | 1,021.31 Bn | - |
| 4 | BeOne Medicines | 467.89 Bn | 463.10 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.19 Bn | 61.44 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.46 Bn | 63.46 Bn | - |
| 8 | Argenx Se | 55.64 Bn | 50.45 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.77% |
| Dec 31, 2025 | 38.29% |
| Sep 30, 2025 | -54.49% |
| Jun 30, 2025 | 18.70% |
| Mar 31, 2025 | -15.18% |
| Dec 31, 2024 | -2.51% |
| Sep 30, 2024 | 13.24% |
| Jun 30, 2024 | 102.12% |
| Mar 31, 2024 | -42.89% |
| Dec 31, 2023 | 23.28% |
| Sep 30, 2023 | 46.53% |
| Jun 30, 2023 | 156.37% |
| Mar 31, 2023 | -70.07% |
| Dec 31, 2022 | -2.96% |
| Sep 30, 2022 | 57.69% |
| Jun 30, 2022 | 208.93% |
| Mar 31, 2022 | -55.69% |
| Dec 31, 2021 | -11.57% |
| Sep 30, 2021 | 38.06% |
| Jun 30, 2021 | 439.92% |